Saul Centers Inc
NYSE:BFS
Saul Centers Inc
NYSE:BFS
Price:
33.87
USD
0.62%
Market Cap:
$829.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Saul Centers Inc
NYSE:BFS
|
US |
|
Z
|
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
|
CN |
|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
US |
|
Ascletis Pharma Inc
HKEX:1672
|
CN |
|
FRONTEO Inc
TSE:2158
|
JP |
|
E
|
East Asia Holdings Investment Ltd
KOSDAQ:900110
|
HK |
Balance Sheet
Balance Sheet Decomposition
Saul Centers Inc
Saul Centers Inc
Balance Sheet Decomposition is not available for
Saul Centers Inc
Saul Centers Inc
Balance Sheet
Saul Centers Inc
Saul Centers Inc
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
45
|
34
|
8
|
8
|
6
|
13
|
21
|
13
|
12
|
12
|
17
|
12
|
10
|
8
|
11
|
15
|
14
|
27
|
15
|
13
|
8
|
10
|
9
|
|
| Cash Equivalents |
1
|
45
|
34
|
8
|
8
|
6
|
13
|
21
|
13
|
12
|
12
|
17
|
12
|
10
|
8
|
11
|
15
|
14
|
27
|
15
|
13
|
8
|
10
|
9
|
|
| Total Receivables |
13
|
15
|
21
|
23
|
33
|
34
|
38
|
38
|
36
|
39
|
41
|
44
|
47
|
51
|
53
|
54
|
54
|
52
|
65
|
59
|
56
|
56
|
51
|
61
|
|
| Accounts Receivables |
13
|
15
|
21
|
23
|
33
|
34
|
38
|
38
|
36
|
39
|
41
|
44
|
47
|
51
|
53
|
54
|
54
|
52
|
65
|
59
|
56
|
56
|
51
|
61
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
4
|
3
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
6
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
17
|
62
|
57
|
34
|
44
|
42
|
54
|
61
|
52
|
55
|
57
|
65
|
63
|
66
|
66
|
70
|
74
|
72
|
97
|
73
|
70
|
64
|
61
|
70
|
|
| PP&E Net |
354
|
387
|
501
|
567
|
628
|
657
|
775
|
835
|
927
|
1 091
|
1 113
|
1 095
|
1 164
|
1 197
|
1 243
|
1 315
|
1 423
|
1 518
|
1 518
|
1 634
|
1 723
|
1 894
|
2 026
|
2 056
|
|
| PP&E Gross |
354
|
387
|
501
|
567
|
628
|
657
|
775
|
835
|
927
|
1 091
|
1 113
|
1 095
|
1 164
|
1 197
|
1 243
|
1 315
|
1 423
|
1 518
|
1 518
|
1 634
|
1 723
|
1 894
|
2 026
|
2 056
|
|
| Accumulated Depreciation |
150
|
165
|
181
|
195
|
214
|
233
|
253
|
276
|
297
|
326
|
353
|
365
|
397
|
425
|
458
|
488
|
526
|
564
|
608
|
650
|
689
|
729
|
768
|
812
|
|
| Other Long-Term Assets |
16
|
20
|
23
|
26
|
24
|
23
|
23
|
23
|
25
|
33
|
34
|
36
|
37
|
27
|
26
|
27
|
28
|
24
|
27
|
24
|
22
|
24
|
26
|
26
|
|
| Other Assets |
1
|
2
|
3
|
4
|
6
|
5
|
3
|
6
|
9
|
13
|
3
|
3
|
4
|
5
|
8
|
10
|
3
|
5
|
3
|
15
|
19
|
12
|
13
|
11
|
|
| Total Assets |
389
N/A
|
472
+21%
|
583
+24%
|
632
+8%
|
701
+11%
|
727
+4%
|
854
+17%
|
926
+8%
|
1 014
+10%
|
1 193
+18%
|
1 207
+1%
|
1 199
-1%
|
1 267
+6%
|
1 295
+2%
|
1 343
+4%
|
1 423
+6%
|
1 528
+7%
|
1 618
+6%
|
1 646
+2%
|
1 747
+6%
|
1 833
+5%
|
1 994
+9%
|
2 126
+7%
|
2 163
+2%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
9
|
8
|
12
|
14
|
16
|
13
|
22
|
23
|
24
|
23
|
27
|
17
|
24
|
28
|
21
|
23
|
32
|
35
|
24
|
26
|
40
|
54
|
44
|
36
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
3
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
8
|
10
|
10
|
11
|
12
|
13
|
13
|
12
|
12
|
13
|
14
|
13
|
14
|
15
|
18
|
19
|
19
|
19
|
19
|
22
|
23
|
23
|
23
|
24
|
|
| Total Current Liabilities |
17
|
17
|
23
|
25
|
28
|
26
|
35
|
36
|
36
|
36
|
41
|
31
|
38
|
43
|
39
|
42
|
52
|
55
|
44
|
47
|
66
|
80
|
70
|
61
|
|
| Long-Term Debt |
381
|
357
|
454
|
482
|
522
|
533
|
568
|
637
|
711
|
832
|
828
|
820
|
857
|
867
|
900
|
959
|
1 022
|
1 091
|
1 151
|
1 144
|
1 223
|
1 387
|
1 533
|
1 602
|
|
| Minority Interest |
0
|
0
|
0
|
3
|
6
|
5
|
3
|
1
|
0
|
43
|
40
|
38
|
47
|
50
|
55
|
59
|
69
|
68
|
63
|
125
|
121
|
156
|
165
|
169
|
|
| Other Liabilities |
5
|
5
|
6
|
10
|
12
|
15
|
23
|
27
|
27
|
31
|
31
|
33
|
33
|
32
|
31
|
29
|
29
|
29
|
23
|
25
|
23
|
23
|
23
|
23
|
|
| Total Liabilities |
402
N/A
|
379
-6%
|
482
+27%
|
520
+8%
|
568
+9%
|
579
+2%
|
629
+9%
|
701
+11%
|
774
+10%
|
943
+22%
|
940
0%
|
922
-2%
|
975
+6%
|
992
+2%
|
1 025
+3%
|
1 088
+6%
|
1 172
+8%
|
1 243
+6%
|
1 281
+3%
|
1 342
+5%
|
1 433
+7%
|
1 646
+15%
|
1 791
+9%
|
1 855
+4%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
100
|
100
|
100
|
100
|
100
|
180
|
180
|
180
|
180
|
180
|
180
|
180
|
180
|
180
|
180
|
180
|
185
|
185
|
185
|
185
|
185
|
185
|
185
|
|
| Retained Earnings |
93
|
99
|
106
|
112
|
110
|
113
|
119
|
124
|
129
|
145
|
155
|
173
|
174
|
180
|
189
|
198
|
209
|
221
|
242
|
256
|
274
|
289
|
307
|
338
|
|
| Additional Paid In Capital |
79
|
92
|
107
|
123
|
142
|
162
|
164
|
169
|
190
|
218
|
247
|
270
|
288
|
305
|
328
|
353
|
385
|
411
|
421
|
437
|
446
|
450
|
454
|
459
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
40
|
43
|
2
|
3
|
1
|
|
| Total Equity |
13
N/A
|
93
N/A
|
101
+9%
|
111
+10%
|
132
+19%
|
149
+13%
|
225
+51%
|
225
0%
|
240
+7%
|
250
+4%
|
268
+7%
|
277
+3%
|
293
+6%
|
303
+4%
|
319
+5%
|
334
+5%
|
356
+6%
|
375
+5%
|
364
-3%
|
405
+11%
|
401
-1%
|
348
-13%
|
336
-4%
|
308
-8%
|
|
| Total Liabilities & Equity |
389
N/A
|
472
+21%
|
583
+24%
|
632
+8%
|
701
+11%
|
727
+4%
|
854
+17%
|
926
+8%
|
1 014
+10%
|
1 193
+18%
|
1 207
+1%
|
1 199
-1%
|
1 267
+6%
|
1 295
+2%
|
1 343
+4%
|
1 423
+6%
|
1 528
+7%
|
1 618
+6%
|
1 646
+2%
|
1 747
+6%
|
1 833
+5%
|
1 994
+9%
|
2 126
+7%
|
2 163
+2%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
15
|
16
|
16
|
17
|
17
|
18
|
18
|
18
|
19
|
19
|
20
|
21
|
21
|
21
|
22
|
22
|
23
|
23
|
24
|
24
|
24
|
24
|
24
|
25
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
